| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Invoke AI is a company that provides a leading creative engine for Stable Diffusion models, empowering professionals, artists, and enthusiasts to generate and augment visual media.
Modernize your cybersecurity with our complete data security solution for enterprises looking to detect insider threats, prevent data breaches and meet compliance.
International Business Machines Corporation is an American multinational technology company headquartered in Armonk, New York, with operations in over 170 countries.
Buy and trade Bitcoin, Ethereum, and other cryptocurrencies with confidence. EQONEX is built for the long term, focusing on regulation, reputation, governance, oversight, security, and fairness.